Be the first to like this
During drug discovery, collaborations can ensure that points in the system where bottlenecks occur can be kept wide open. Programs like ‘fast track designation’, ‘translational research’ as well as ‘public/private collaborations’, all aim to serve the essential needs of manufacturers to speed up the process overall.
Read the full article on “Targeted therapies: speed and collaboration” to find out what makes public/private collaborations so powerful and how the largest collaborations of its type might serve as a model for other huge projects in the future.
Read the full 5-page article here: http://bit.ly/1q0wmaT